Tag: Diabetes: Type II
Short, Intense Workouts Offer CV Benefits for T2DM Patients
Intermittent high-intensity exercise might also improve diabetes control, researchers say
Bariatric Surgery Beats Drug Tx for Metabolic Outcomes in T2DM
Surgery associated with significantly lower plasma lipids, CV risk, medication use versus drug therapy
Modest Relation Between HbA1c, Cardiovascular Events
No statistically significant interaction for difference seen for those with, without vascular disease
Type 2 Diabetes Linked to More Alzheimer’s Neuropathology
Effect may be driven by tau phosphorylation, researchers say
Antibiotic Use Linked to Higher Type 2 Diabetes Risk
Researchers don't know if the drugs signal developing disease, or contribute to it
Patient Satisfaction Up for Dulaglutide Treatment in T2DM
Improvement in patient satisfaction, decrease in perceived frequency of hyperglycemia
Misdiagnosis of T2DM Reported in Patient With Hb Wayne
Consistently elevated HbA1c seen with HPLC testing, but not with immunoassay
Bulimia Nervosa Tied to Increased Risk of Type 2 Diabetes
Increased risk in patients versus controls; higher lifetime prevalence for patients, especially males
Long-Acting Analog Insulin Doesn’t Up AMI Risk in T2DM
No significant difference in risk for long-acting analog, other basal insulin therapies
Liraglutide Linked to Weight Loss Over 56 Weeks in T2DM
More weight loss for 3.0 mg liraglutide versus placebo among overweight/obese with type 2 diabetes
